Prospective, Open Label Study to Assess 24hs IOP Recorded With Triggerfish® in Patients With OAG … (NCT05876936) | Clinical Trial Compass
TerminatedNot Applicable
Prospective, Open Label Study to Assess 24hs IOP Recorded With Triggerfish® in Patients With OAG Before and After DSCI
Stopped: Principal investigator left the hospital
Switzerland5 participantsStarted 2013-12
Plain-language summary
A prospective, open label study to assess the 24-hour intraocular pressure pattern recorded with SENSIMED Triggerfish® in patients with open angle glaucoma before and after deep sclerectomy with collagen implant
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of Open Angle Glaucoma (OAG)
* Documented glaucomatous Visual Field damage with MD more negative than -2 dB
* Progressing glaucomatous damage justifying a deep sclerectomy with collagen implant (DSCI)
* Aged ≥18 years, of either sex
* Not more than 6 diopters spherical equivalent on the study eye
* Have given written informed consent, prior to any investigational procedures
Exclusion Criteria:
* • History of ocular surgery within the last 3 months on the study eye
* History of ocular laser treatment on the study eye
* Corneal or conjunctival abnormality precluding contact lens adaptation on the study eye
* Severe dry eye syndrome on the study eye
* Patients with allergy to corneal anesthetic
* Patients with contraindications for silicone contact lens wear
* Patients not able to understand the character and individual consequences of the investigation
* Participation in other clinical research within the last 4 weeks
* Any other contra-indication listed in the SENSIMED Triggerfish® user manual
What they're measuring
1
Changes between the nycthemeral IOP patterns recorded with TF during two 24-hour periods in patients with OAG